Reset Therapeutics
About:
Reset Therapeutics, a biopharmaceutical company, develops and commercializes products that modulate the circadian system of the human body.
Website: http://resettherapeutics.com
Twitter/X: resettx
Description:
Reset Therapeutics is a biopharmaceutical company formed to discover, develop and commercialize new therapeutics that modulate the circadian system, the body’s network of internal molecular clocks.
Total Funding Amount:
$53.6M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
South San Francisco, California, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)resettherapeutics.com
Founders:
Ross Bersot
Number of Employees:
11-50
Last Funding Date:
2016-02-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai